Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Kohl's Corporation (KSS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Kohl's Corporation — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B), while Kohl's Corporation trades at $21.11 (market cap $2.39B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.9× Kohl's Corporation's market cap, and Kohl's Corporation pays a 2.37% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Kohl's Corporation for 48 Days on average.
| IONS | KSS | |
|---|---|---|
Market Cap | $7.04B | $2.39B |
Volume | 2,977,440 | 4,591,325 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $24.71 |
52-Week Low | $42.38 | $11.72 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $6.60B | $7.99B |
Dividend Yield | — | 2.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kohl's (KSS) trades at $21.10, down 0.33% on the day, with a bullish technical signal from moving averages and a low valuation profile (P/E 9.06, P/S 0.16). Recent earnings beats in Q4 2025 and Q1-Q2 2026, alongside a raised full-year outlook, highlight improving operational momentum, though revenue has declined from $19.4B in 2022 to $16.2B in 2025. The company maintains a dividend, with the next payment of $0.13 scheduled for September 23, 2026.
The stock presents a value opportunity with attractive multiples and positive earnings surprises, but faces headwinds from 18 consecutive quarters of sales declines and competitive pressures. Analyst sentiment is mixed with a 30% buy rating, and the consensus price target of $15.50 implies downside risk from current levels. Execution on holiday sales and margin stabilization are critical for sustaining the recent rebound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →
